AngioDynamics has reshaped its portfolio into a two‑segment model and concentrated on a higher‑growth Med Tech segment; management said Med Tech grew nearly 20% in the first six months, margins and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results